[Hypogonadism in patients with testicular tumors and prostate cancer].
Hypogonadism is defined as an array of symptoms arising from a deficiency of androgens. It is caused by a hormonal and spermatogenic dysfunction of the testes. It results in impaired fertility and has a negative impact on the functions of multiple organs and systems, physical well-being, sexual functions and also mental state. Particularly patients with a history of cancer have a high risk of developing hypogonadism as a result of not only the nature of the disease, but mainly its treatment. While leaving the patient with cancer without treatment does not fall within the concept of the art of medicine and the ethical canon of a physician, the symptoms of hypogonadism are often ignored and left untreated. Among urological patients special attention should be given to those with testicular tumors and prostate cancer.
Klinika Urologii Onkologicznej, Czynnościowej I Ogólnej, Centralny Szpital Kliniczny - Wojskowy Instytut Medyczny, Warszawa, Polska, Centrum Płodności Fertimedica, Warszawa, Polska.
Marcin
M
Radko
Klinika Urologii Onkologicznej, Czynnościowej I Ogólnej, Centralny Szpital Kliniczny - Wojskowy Instytut Medyczny, Warszawa, Polska.
Tomasz
T
Syryło
Klinika Urologii Onkologicznej, Czynnościowej I Ogólnej, Centralny Szpital Kliniczny - Wojskowy Instytut Medyczny, Warszawa, Polska.
Henryk
H
Zieliński
D006801:Humans; D007006:Hypogonadism / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D008297:Male; D011471:Prostatic Neoplasms / Q000150:complications*; D013736:Testicular Neoplasms / Q000150:complications*
 prostate cancer;  testicular tumors ;  testosterone; hypogonadism